Role of corneal neuropeptides in the pathogenesis of herpetic stromal keratitis
角膜神经肽在疱疹性基质性角膜炎发病机制中的作用
基本信息
- 批准号:7875060
- 负责人:
- 金额:$ 21.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-04-01 至 2012-03-31
- 项目状态:已结题
- 来源:
- 关键词:Adrenal Cortex HormonesAdverse effectsAnti-Inflammatory AgentsAnti-inflammatoryBlindnessC57BL/6 MouseCD4 Positive T LymphocytesCell physiologyCellsChronicCicatrixCorneaCorneal OpacityCorneal StromaDevelopmentDiseaseEyeGoalsHerpesvirus 1Herpetic KeratitisImmuneImmunityInfectionInflammationInflammatoryInterleukin-1Interleukin-1 ReceptorsInterleukin-10Interleukin-2Interleukin-6KeratitisLeftLesionMacrophage Inflammatory Protein-1MediatingMusNerve FibersNeuropeptidesOcular PathologyPathogenesisPharmaceutical PreparationsPilot ProjectsReactionRecombinantsRecurrenceReportingRoleSeveritiesSubstance PTestingTissuesTopical CorticosteroidsUnited StatesVascular Endothelial Growth FactorsVasoactive Intestinal PeptideViralVirusangiogenesiscell typechemokinecytokinemouse modelneutrophilnovel strategiesnovel therapeutic interventionpublic health relevance
项目摘要
DESCRIPTION (provided by applicant): Herpes simplex virus-1 (HSV-1) recurrences can cause many ocular pathologies including, immune cell mediated chronic inflammation in the corneal stroma. If left untreated, the chronic immunoinflammatory reactions in the corneal stroma can give rise to herpetic stromal keratitis (HSK); a disease that results in permanent scarring of the cornea and is a leading cause of infection induced corneal blindness in the United States. The current therapies to manage the HSK lesions have significant downsides. Therefore, investigating novel approaches to control the severity of HSK lesions are urgently needed. In this study, we will explore the role of corneal neuropeptides, substance P (SP) and vasoactive intestinal peptide (VIP), in the progression and severity of HSK lesions in a mouse model. Our long-term goal is to understand the role of neuropeptides in regulating the immunity to HSV-1 infection. Neuropeptides SP and VIP are reported to have differential roles in promoting or inhibiting the inflammation. Our pilot studies demonstrated higher amounts of SP but lower levels of VIP in the mice corneas with severe HSK lesions in comparison to those with mild HSK lesions. Therefore, we hypothesize that neuropeptides SP and VIP in the inflamed cornea regulate the progression and severity of HSK lesions. The development of HSK lesions is immune-mediated, with the involvement of pro-inflammatory cytokines (IL-1, IL-6, IL-2, IFN-3 and TNF-1), chemokines (MIP-1 and MIP-2), and immune cell types such as neutrophils and CD4 T cells. Therefore, we will test our hypothesis by demonstrating that corneal neuropeptides SP and VIP regulate the amounts of pro- and anti-inflammatory cytokines, and chemokines in HSV-1 infected corneas. We will also demonstrate that SP and VIP regulate the influx, survival and effector function of neutrophils and CD4 T cells in virus infected corneas. We anticipate that our findings will provide a novel approach to elucidate the pathogenesis of HSK and may significantly impact the management of this condition.
PUBLIC HEALTH RELEVANCE: Recurrent herpes simplex virus type-1 (HSV-1) infection of the cornea results in the development of herpetic stromal keratitis (HSK), a disease that can cause permanent scarring and loss of vision. The current therapies to control HSK have significant drawbacks. In this study, we will investigate a novel approach to manage HSK in a mouse model by understanding the role of corneal neuropeptides in the progression and severity of HSK.
描述(申请人提供):单纯疱疹病毒-1(HSV-1)复发可导致许多眼部病理,包括免疫细胞介导的角膜基质慢性炎症。如果不进行治疗,角膜基质中的慢性免疫炎症反应可能会导致疱疹间质角膜炎(HSK);这是一种导致角膜永久疤痕的疾病,是美国感染导致角膜失明的主要原因。目前治疗HSK皮损的方法有很大的缺点。因此,迫切需要研究新的方法来控制HSK病变的严重程度。在本研究中,我们将探讨P物质(SP)和血管活性肠肽(VIP)这两种角膜神经肽在单纯疱疹病毒性角膜炎(HSK)小鼠病变进展和严重程度中的作用。我们的长期目标是了解神经肽在调节对HSV-1感染的免疫中的作用。据报道,神经肽SP和VIP在促进或抑制炎症方面具有不同的作用。我们的初步研究表明,与轻度HSK损害相比,严重HSK损害的小鼠角膜中SP含量更高,而VIP水平更低。因此,我们推测炎症角膜中的神经肽SP和VIP调节HSK病变的进展和严重程度。HSK病变的发展是免疫介导的,参与了促炎细胞因子(IL-1、IL-6、IL-2、干扰素-3和肿瘤坏死因子-1)、趋化因子(MIP-1和MIP-2)以及中性粒细胞和CD4T细胞等免疫细胞类型。因此,我们将通过证明角膜神经肽SP和VIP调节HSV-1感染的角膜中促炎症和抗炎细胞因子以及趋化因子的数量来检验我们的假设。我们还将展示SP和VIP调节病毒感染的角膜中性粒细胞和CD4T细胞的流入、存活和效应功能。我们预计,我们的发现将为阐明HSK的发病机制提供一种新的方法,并可能对这种疾病的治疗产生重大影响。
公共卫生相关性:反复感染角膜的单纯疱疹病毒1型(HSV-1)会导致疱疹间质角膜炎(HSK),这是一种可导致永久性疤痕和失明的疾病。目前控制单纯疱疹病毒性角膜炎的治疗方法有明显的缺陷。在这项研究中,我们将通过了解角膜神经肽在HSK的进展和严重程度中的作用,来探索一种新的方法来处理小鼠模型中的HSK。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Susmit Suvas其他文献
Susmit Suvas的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Susmit Suvas', 18)}}的其他基金
CXCR4: A potential therapeutic target in HSK
CXCR4:HSK 的潜在治疗靶点
- 批准号:
10752865 - 财政年份:2023
- 资助金额:
$ 21.8万 - 项目类别:
Role of insulin-like growth factor binding proteins in the pathogenesis of herpes stromal keratitis.
胰岛素样生长因子结合蛋白在疱疹基质角膜炎发病机制中的作用。
- 批准号:
10468069 - 财政年份:2020
- 资助金额:
$ 21.8万 - 项目类别:
Role of insulin-like growth factor binding proteins in the pathogenesis of herpes stromal keratitis.
胰岛素样生长因子结合蛋白在疱疹基质角膜炎发病机制中的作用。
- 批准号:
10056782 - 财政年份:2020
- 资助金额:
$ 21.8万 - 项目类别:
Role of insulin-like growth factor binding proteins in the pathogenesis of herpes stromal keratitis.
胰岛素样生长因子结合蛋白在疱疹基质角膜炎发病机制中的作用。
- 批准号:
10219263 - 财政年份:2020
- 资助金额:
$ 21.8万 - 项目类别:
Role of insulin-like growth factor binding proteins in the pathogenesis of herpes stromal keratitis.
胰岛素样生长因子结合蛋白在疱疹基质角膜炎发病机制中的作用。
- 批准号:
10673185 - 财政年份:2020
- 资助金额:
$ 21.8万 - 项目类别:
Interplay between hypoxia and oxidative phosphorylation in herpes stromal keratitis
疱疹性基质角膜炎中缺氧与氧化磷酸化之间的相互作用
- 批准号:
10357859 - 财政年份:2019
- 资助金额:
$ 21.8万 - 项目类别:
Interplay between hypoxia and oxidative phosphorylation in herpes stromal keratitis
疱疹性基质角膜炎中缺氧与氧化磷酸化之间的相互作用
- 批准号:
10586030 - 财政年份:2019
- 资助金额:
$ 21.8万 - 项目类别:
Corneal neuropeptides and herpetic stromal keratitis
角膜神经肽与疱疹性基质角膜炎
- 批准号:
8616376 - 财政年份:2013
- 资助金额:
$ 21.8万 - 项目类别:
Corneal neuropeptides and herpetic stromal keratitis
角膜神经肽与疱疹性基质角膜炎
- 批准号:
8504248 - 财政年份:2013
- 资助金额:
$ 21.8万 - 项目类别:
Corneal neuropeptides and herpetic stromal keratitis
角膜神经肽与疱疹性基质角膜炎
- 批准号:
9248405 - 财政年份:2013
- 资助金额:
$ 21.8万 - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 21.8万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 21.8万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 21.8万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 21.8万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 21.8万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 21.8万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 21.8万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 21.8万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 21.8万 - 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
- 批准号:
RGPIN-2018-04753 - 财政年份:2022
- 资助金额:
$ 21.8万 - 项目类别:
Discovery Grants Program - Individual